Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJMBR (2) Anais da ABC (AABC) (1) Ciência Rural (1) Autor Zuardi,A.W. (2) Barbalho,Sandra Maria (1) Callejas,G.H. (1) Crippa,J.A. (1) Crippa,J.A.S. (1) Figueira,R.L. (1) Friolani,Milena (1) Girio,Raul José Silva (1) Gonçalves,F.L.L. (1) Guimarães,F.S. (1) Hallak,J.E. (1) Hallak,J.E.C. (1) MADAKA,FAMEERA (1) MONTON,CHAOWALIT (1) Moreira,F.A. (1) Repetti,Cláudia Sampaio Fonseca (1) SETTHARAKSA,SUKANYA (1) SONGSAK,THANAPAT (1) SUKSAEREE,JIRAPORNCHAI (1) Sbragia,L. (1) Mais... Palavra-chave Cannabidiol (4) Antipsychotic (1) Anxiety (1) Cannabinoid (1) Cannabinoids (1) Cannabis sativa (1) D9-Tetrahydrocannabinol (1) Experimental model (1) Gastroschisis (1) Oncology. (1) Optimization (1) Pain (1) Prenatal treatment (1) Schizophrenia (1) Δ9-tetrahydrocannabinol (1) Mais... Tipo do documento Info:eu-repo/semantics/article (4) Ano 2019 (2) 2018 (1) 2006 (1) País Brazil (4) Idioma Inglês (4)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 4 Primeira ... 1 ... Última Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug BJMBR Zuardi,A.W.; Crippa,J.A.S.; Hallak,J.E.C.; Moreira,F.A.; Guimarães,F.S.. A high dose of delta9-tetrahydrocannabinol, the main Cannabis sativa (cannabis) component, induces anxiety and psychotic-like symptoms in healthy volunteers. These effects of delta9-tetrahydrocannabinol are significantly reduced by cannabidiol (CBD), a cannabis constituent which is devoid of the typical effects of the plant. This observation led us to suspect that CBD could have anxiolytic and/or antipsychotic actions. Studies in animal models and in healthy volunteers clearly suggest an anxiolytic-like effect of CBD. The antipsychotic-like properties of CBD have been investigated in animal models using behavioral and neurochemical techniques which suggested that CBD has a pharmacological profile similar to that of atypical antipsychotic drugs. The results... Tipo: Info:eu-repo/semantics/article Palavras-chave: Cannabidiol; D9-Tetrahydrocannabinol; Cannabinoid; Anxiety; Antipsychotic; Schizophrenia. Ano: 2006 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000400001 Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model BJMBR Callejas,G.H.; Figueira,R.L.; Gonçalves,F.L.L.; Volpe,F.A.P.; Zuardi,A.W.; Crippa,J.A.; Hallak,J.E.; Sbragia,L.. Gastroschisis (GS) is an abdominal wall defect that results in histological and morphological changes leading to intestinal motility perturbation and impaired absorption of nutrients. Due to its anti-inflammatory, antioxidant, and neuroprotective effects, cannabidiol (CBD) has been used as a therapeutic agent in many diseases. Our aim was to test the effect of maternal CBD in the intestine of an experimental model of GS. Pregnant rats were treated over 3 days with CBD (30 mg/kg) after the surgical induction of GS (day 18.5 of gestation) and compared to controls. Fetuses were divided into 4 groups: 1) control (C); 2) C+CBD (CCBD); 3) gastroschisis (G), and 4) G+CBD (GCBD). On day 21.5 of gestation, the fetuses were harvested and evaluated for: a) body... Tipo: Info:eu-repo/semantics/article Palavras-chave: Gastroschisis; Experimental model; Prenatal treatment; Cannabidiol. Ano: 2018 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2018000500607 Optimal condition of cannabis maceration to obtain the high cannabidiol and Δ9-tetrahydrocannabinol content Anais da ABC (AABC) MONTON,CHAOWALIT; MADAKA,FAMEERA; SETTHARAKSA,SUKANYA; WUNNAKUP,THANIYA; SUKSAEREE,JIRAPORNCHAI; SONGSAK,THANAPAT. Abstract: The aim of this work was to optimize a maceration condition of cannabis (Cannabis sativa L.). A circumscribed central composite experimental design was applied in this work. Temperature and time were varied from 40-80 °C and 30-90 min, respectively. The three responses (i.e., extraction yield, cannabidiol content, and Δ9- tetrahydrocannabinol content) were predicted by computer software. The yield was high when cannabis was macerated using ethanol at high temperature and long duration time. While cannabidiol and Δ9- tetrahydrocannabinol content was high when macerating at a low heating temperature and short duration time. The optimal condition provided the simultaneous high of cannabidiol and Δ9- tetrahydrocannabinol content was 40 °C for 30 min.... Tipo: Info:eu-repo/semantics/article Palavras-chave: Cannabis sativa; Cannabidiol; Δ9-tetrahydrocannabinol; Optimization. Ano: 2019 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652019000500809 Perspectives in veterinary medicine on the use of cannabinoids as complementary palliative therapy for pain in cancer patients Ciência Rural Repetti,Cláudia Sampaio Fonseca; Girio,Raul José Silva; Friolani,Milena; Barbalho,Sandra Maria. ABSTRACT: Pain in the cancer patient is an important clinical manifestation that results in low life expectancy and poor prognosis. Pain may be related to tumor type, invasion of adjacent tissues, metastasis, and diagnostic and therapeutic procedures with variable response to analgesic therapy. Many studies have called attention due to their potential therapeutic effect in the modulation of pain and inflammation. Cannabinoid derivatives are chemical compounds obtained from Cannabis that act on specific receptors.Several commercial products have already been approved in Europe and the USA for use in human patients. The present study aimed to review articles on the use of cannabinoids in the control of pain contributing to the well-being and quality of life... Tipo: Info:eu-repo/semantics/article Palavras-chave: Pain; Cannabinoids; Cannabidiol; Oncology.. Ano: 2019 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-84782019000200600 Registros recuperados: 4 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco